Drug Discoveries & Therapeutics
Online ISSN : 1881-784X
Print ISSN : 1881-7831
ISSN-L : 1881-7831
Case Report
Angiosarcoma of the thoracic wall responded well to nanoparticle albumin-bound paclitaxel: A case report
Naofumi Hara, Nobukazu Fujimoto, Yosuke Miyamoto, Tomoko Yamagishi, Michiko Asano, Yasuko Fuchimoto, Sae Wada, Shinji Ozaki, Hideyuki Nishi, Takumi Kishimoto
Author information
JOURNAL FREE ACCESS

2016 Volume 10 Issue 2 Pages 114-116

Details
Abstract
An 81-year-old woman visited a local clinic due to chest pain and a skin induration on the right precordia. She had a history of right breast cancer, and she had undergone a mastectomy and radiation therapy 10 years prior. Computed tomography (CT) imaging of the chest demonstrated a lobular mass that involved the right anterior thoracic wall and partially extruded from the thoracic cavity into the subcutaneous tissue. The tumor was surgically excised, and pathological analyses yielded a diagnosis of angiosarcoma. Five months after the operation, CT imaging showed multiple masses on the right pleura, indicating a local relapse and pleural dissemination of the angiosarcoma. Systemic chemotherapy composed of nanoparticle albumin-bound paclitaxel (nab-PTX) (80 mg/m2) was delivered weekly. After 4 courses of chemotherapy, the tumors regressed remarkably. Nab-PTX may be an effective treatment option for recurrent or metastatic angiosarcoma.
Content from these authors
© 2016 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
Previous article Next article
feedback
Top